Zoledronic acid exacerbates inflammation through M1 macrophage polarization
Abstract Background Zoledronic acid (Zol), one of the bisphosphonates, is frequently utilized for the treatment of osteoporosis and bone metastasis. However, the onset of medication-related osteonecrosis of the jaw (MRONJ) following dental treatments has become a serious issue. We reported previousl...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central
2018-06-01
|
Series: | Inflammation and Regeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41232-018-0074-9 |